Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here we describe a patient with dyspnea and general weakness because of complete atrioventricular block while receiving bortezomib. We immediately stopped bortezomib, and after inserting a permanent VDD pacemaker, the patients' symptoms disappeared.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017698 | PMC |
| http://dx.doi.org/10.3349/ymj.2011.52.1.196 | DOI Listing |
Publication Analysis
Top Keywords
complete atrioventricular
8
atrioventricular block
8
multiple myeloma
8
bortezomib
5
block secondary
4
secondary bortezomib
4
bortezomib multiple
4
myeloma bortezomib
4
bortezomib inhibitor
4
inhibitor 26s
4